Emcure Pharma IPO Sizzles with 67.87x Subscription; ₹331 GMP Sparks Anticipation for Allotment Day
The initial public offering (IPO) of Emcure Pharmaceuticals Limited has received a strong response from investors. The bidding for this IPO ended last Friday, and the issue worth ₹1,952.03 crore was oversubscribed 67.87 times. With the bidding over, attention now turns to the allotment of shares, expected on Monday, 8th July 2024. In the grey market, Emcure’s shares are still trading at a premium of ₹331, showing steady demand.
Emcure Pharma IPO GMP Today
The grey market premium (GMP) for Emcure Pharma IPO remains steady at ₹331, the same as it was on Friday. Market experts suggest that this stability is due to positive market sentiment and the strong subscription rates for the IPO. They expect the grey market to continue being optimistic about Emcure Pharma.
Emcure Pharma IPO Subscription Status
During the three-day bidding period from 3rd to 5th July 2024, Emcure Pharma’s IPO was oversubscribed 67.87 times. The retail portion was subscribed 7.21 times, non-institutional investors (NII) subscribed 48.32 times, and qualified institutional buyers (QIB) subscribed 195.83 times. This indicates significant interest from both NII and QIB investors.
Emcure Pharma IPO Allotment and Listing Dates
Under the ‘T+3’ rule, the likely date for the share allotment is Monday, 8th July 2024. Following this, the shares are expected to be listed on Wednesday, 10th July 2024.
How to Check Emcure Pharma IPO Allotment Status
Once the shares are allocated, investors can check their allotment status online. This can be done via the BSE website or through the official registrar for the IPO, Link Intime India Private Limited.
Links for Allotment Status:
With the high subscription rates and positive grey market premium, investors are eagerly awaiting the allotment results and the stock’s market debut.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
